GILD logo

Gilead Sciences (GILD) Net Income

Annual Net Income

$5.67 B
+$1.07 B+23.37%

31 December 2023

GILD Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Net Income

$1.25 B
-$361.00 M-22.37%

30 September 2024

GILD Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Net Income

$126.00 M
-$927.00 M-88.03%

30 September 2024

GILD TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GILD Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+23.4%-42.5%-97.9%
3 y3 years+4505.7%-51.7%-98.3%
5 y5 years+3.9%+207.6%-95.3%

GILD Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-9.0%+4505.7%-51.7%+130.1%-98.3%at low
5 y5 years-9.0%+4505.7%-53.5%+130.1%-98.3%+149.0%
alltimeall time-68.7%+576.1%-73.2%+130.1%-99.3%+110.6%

Gilead Sciences Net Income History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.25 B(-22.4%)
$126.00 M(-88.0%)
June 2024
-
$1.61 B(-138.7%)
$1.05 B(+117.6%)
Mar 2024
-
-$4.17 B(-391.8%)
$484.00 M(-91.5%)
Dec 2023
$5.67 B(+23.4%)
$1.43 B(-34.4%)
$5.66 B(-3.6%)
Sept 2023
-
$2.18 B(+108.6%)
$5.88 B(+7.1%)
June 2023
-
$1.04 B(+3.5%)
$5.48 B(-1.8%)
Mar 2023
-
$1.01 B(-38.4%)
$5.58 B(+21.6%)
Dec 2022
$4.59 B(-26.2%)
$1.64 B(-8.3%)
$4.59 B(+37.7%)
Sept 2022
-
$1.79 B(+56.4%)
$3.33 B(-19.4%)
June 2022
-
$1.14 B(+5921.1%)
$4.14 B(-8.4%)
Mar 2022
-
$19.00 M(-95.0%)
$4.51 B(-27.5%)
Dec 2021
$6.22 B(+4961.0%)
$382.00 M(-85.3%)
$6.22 B(-15.8%)
Sept 2021
-
$2.59 B(+70.3%)
$7.39 B(+43.2%)
June 2021
-
$1.52 B(-12.0%)
$5.16 B(+1615.0%)
Mar 2021
-
$1.73 B(+11.5%)
$301.00 M(+144.7%)
Dec 2020
$123.00 M(-97.7%)
$1.55 B(+330.8%)
$123.00 M(-90.3%)
Sept 2020
-
$360.00 M(-110.8%)
$1.27 B(-593.4%)
June 2020
-
-$3.34 B(-315.3%)
-$257.00 M(-105.2%)
Mar 2020
-
$1.55 B(-42.5%)
$4.96 B(-7.9%)
Dec 2019
$5.39 B(-1.3%)
$2.70 B(-331.4%)
$5.39 B(+100.0%)
Sept 2019
-
-$1.17 B(-162.0%)
$2.69 B(-54.8%)
June 2019
-
$1.88 B(-4.8%)
$5.96 B(+1.1%)
Mar 2019
-
$1.98 B(>+9900.0%)
$5.89 B(+8.0%)
Dec 2018
$5.46 B(+17.9%)
$3.00 M(-99.9%)
$5.46 B(+243.7%)
Sept 2018
-
$2.10 B(+15.4%)
$1.59 B(-28.1%)
June 2018
-
$1.82 B(+18.1%)
$2.21 B(-36.3%)
Mar 2018
-
$1.54 B(-139.8%)
$3.46 B(-25.2%)
Dec 2017
$4.63 B(-65.7%)
-$3.87 B(-242.2%)
$4.63 B(-60.1%)
Sept 2017
-
$2.72 B(-11.6%)
$11.60 B(-5.0%)
June 2017
-
$3.07 B(+13.7%)
$12.21 B(-3.4%)
Mar 2017
-
$2.70 B(-13.1%)
$12.64 B(-6.4%)
Dec 2016
$13.50 B(-25.4%)
$3.11 B(-6.7%)
$13.50 B(-10.4%)
Sept 2016
-
$3.33 B(-4.8%)
$15.08 B(-7.8%)
June 2016
-
$3.50 B(-1.9%)
$16.35 B(-5.7%)
Mar 2016
-
$3.57 B(-23.9%)
$17.34 B(-4.2%)
Dec 2015
$18.11 B(+49.6%)
$4.68 B(+1.8%)
$18.11 B(+7.1%)
Sept 2015
-
$4.60 B(+2.4%)
$16.91 B(+12.4%)
June 2015
-
$4.49 B(+3.7%)
$15.04 B(+5.9%)
Mar 2015
-
$4.33 B(+24.3%)
$14.21 B(+17.4%)
Dec 2014
$12.10 B(+293.5%)
$3.49 B(+27.7%)
$12.10 B(+28.7%)
Sept 2014
-
$2.73 B(-25.3%)
$9.41 B(+26.0%)
June 2014
-
$3.66 B(+64.2%)
$7.46 B(+63.0%)
Mar 2014
-
$2.23 B(+181.3%)
$4.58 B(+48.9%)
Dec 2013
$3.08 B(+18.6%)
$791.60 M(+0.4%)
$3.08 B(+0.9%)
Sept 2013
-
$788.61 M(+2.1%)
$3.05 B(+3.9%)
June 2013
-
$772.61 M(+7.0%)
$2.93 B(+2.1%)
Mar 2013
-
$722.19 M(-5.3%)
$2.87 B(+10.8%)
Dec 2012
$2.59 B(-7.5%)
$762.98 M(+12.9%)
$2.59 B(+3.9%)
Sept 2012
-
$675.50 M(-5.1%)
$2.49 B(-2.6%)
June 2012
-
$711.56 M(+61.0%)
$2.56 B(-1.3%)
Mar 2012
-
$441.96 M(-33.6%)
$2.59 B(-7.5%)
Dec 2011
$2.80 B(-3.4%)
$665.14 M(-10.3%)
$2.80 B(+1.3%)
Sept 2011
-
$741.12 M(-0.7%)
$2.77 B(+1.3%)
June 2011
-
$746.23 M(+14.6%)
$2.73 B(+1.3%)
Mar 2011
-
$651.14 M(+3.5%)
$2.70 B(-7.0%)
Dec 2010
$2.90 B(+10.1%)
$629.42 M(-10.7%)
$2.90 B(-5.6%)
Sept 2010
-
$704.88 M(-1.0%)
$3.07 B(+1.0%)
June 2010
-
$712.06 M(-16.7%)
$3.04 B(+4.8%)
Mar 2010
-
$854.90 M(+6.6%)
$2.90 B(+10.1%)
Dec 2009
$2.64 B(+33.2%)
$802.21 M(+19.2%)
$2.64 B(+11.2%)
Sept 2009
-
$673.03 M(+17.8%)
$2.37 B(+7.7%)
June 2009
-
$571.40 M(-3.0%)
$2.20 B(+6.6%)
Mar 2009
-
$589.11 M(+9.9%)
$2.06 B(+5.1%)
Dec 2008
$1.98 B(+22.5%)
$535.94 M(+6.3%)
$1.96 B(+7.3%)
Sept 2008
-
$504.00 M(+15.9%)
$1.83 B(+6.1%)
June 2008
-
$434.78 M(-11.0%)
$1.72 B(+1.6%)
Mar 2008
-
$488.30 M(+21.6%)
$1.70 B(+5.0%)
Dec 2007
$1.62 B
$401.64 M(+0.8%)
$1.62 B(-457.4%)
Sept 2007
-
$398.32 M(-2.4%)
-$451.99 M(-49.9%)
DateAnnualQuarterlyTTM
June 2007
-
$407.93 M(+0.1%)
-$902.47 M(-13.7%)
Mar 2007
-
$407.41 M(-124.5%)
-$1.05 B(-12.2%)
Dec 2006
-$1.19 B(-246.2%)
-$1.67 B(+3093.1%)
-$1.19 B(-257.1%)
Sept 2006
-
-$52.16 M(-119.7%)
$757.29 M(-23.4%)
June 2006
-
$265.15 M(+0.9%)
$988.69 M(+7.5%)
Mar 2006
-
$262.70 M(-6.7%)
$919.50 M(+13.0%)
Dec 2005
$813.91 M(+81.1%)
$281.60 M(+57.1%)
$813.91 M(+26.7%)
Sept 2005
-
$179.23 M(-8.5%)
$642.56 M(+11.4%)
June 2005
-
$195.97 M(+24.7%)
$576.56 M(+17.2%)
Mar 2005
-
$157.11 M(+42.5%)
$492.06 M(+9.5%)
Dec 2004
$449.37 M(-724.1%)
$110.24 M(-2.6%)
$449.37 M(-15.5%)
Sept 2004
-
$113.24 M(+1.6%)
$531.71 M(+8.2%)
June 2004
-
$111.46 M(-2.6%)
$491.57 M(+2.3%)
Mar 2004
-
$114.43 M(-40.6%)
$480.48 M(-767.3%)
Dec 2003
-$72.00 M(-199.9%)
$192.58 M(+163.5%)
-$72.00 M(-68.6%)
Sept 2003
-
$73.10 M(-27.2%)
-$229.11 M(-18.6%)
June 2003
-
$100.37 M(-122.9%)
-$281.45 M(-22.3%)
Mar 2003
-
-$438.05 M(-1334.7%)
-$362.11 M(-602.2%)
Dec 2002
$72.10 M(+37.9%)
$35.48 M(+70.9%)
$72.10 M(-57.1%)
Sept 2002
-
$20.76 M(+5.3%)
$168.19 M(+37.6%)
June 2002
-
$19.71 M(-612.0%)
$122.24 M(+74.3%)
Mar 2002
-
-$3.85 M(-102.9%)
$70.14 M(+34.2%)
Dec 2001
$52.27 M(-192.1%)
$131.58 M(-622.2%)
$52.27 M(-148.1%)
Sept 2001
-
-$25.20 M(-22.2%)
-$108.57 M(+7.6%)
June 2001
-
-$32.39 M(+49.1%)
-$100.94 M(+39.1%)
Mar 2001
-
-$21.72 M(-25.8%)
-$72.59 M(+2.1%)
Dec 2000
-$56.78 M(-14.6%)
-$29.27 M(+66.6%)
-$71.08 M(+39.9%)
Sept 2000
-
-$17.56 M(+335.2%)
-$50.81 M(-20.2%)
June 2000
-
-$4.04 M(-80.0%)
-$63.65 M(-10.7%)
Mar 2000
-
-$20.21 M(+124.6%)
-$71.30 M(+7.1%)
Dec 1999
-$66.50 M(+48.4%)
-$9.00 M(-70.4%)
-$66.57 M(-12.7%)
Sept 1999
-
-$30.40 M(+160.0%)
-$76.27 M(+74.7%)
June 1999
-
-$11.69 M(-24.5%)
-$43.67 M(-6.6%)
Mar 1999
-
-$15.48 M(-17.2%)
-$46.78 M(+20.9%)
Dec 1998
-$44.80 M(-38.5%)
-$18.70 M(-950.0%)
-$38.70 M(-49.9%)
Sept 1998
-
$2.20 M(-114.9%)
-$77.30 M(-13.9%)
June 1998
-
-$14.80 M(+100.0%)
-$89.80 M(+24.2%)
Mar 1998
-
-$7.40 M(-87.1%)
-$72.30 M(-0.7%)
Dec 1997
-$72.90 M(+235.9%)
-$57.30 M(+456.3%)
-$72.80 M(+209.8%)
Sept 1997
-
-$10.30 M(-481.5%)
-$23.50 M(+502.6%)
June 1997
-
$2.70 M(-134.2%)
-$3.90 M(-79.3%)
Mar 1997
-
-$7.90 M(-1.3%)
-$18.80 M(-13.4%)
Dec 1996
-$21.70 M(-20.8%)
-$8.00 M(-186.0%)
-$21.70 M(+58.4%)
Sept 1996
-
$9.30 M(-176.2%)
-$13.70 M(-56.4%)
June 1996
-
-$12.20 M(+13.0%)
-$31.40 M(+15.9%)
Mar 1996
-
-$10.80 M(+28.6%)
-$27.10 M(-18.9%)
Dec 1995
-$27.40 M(-12.5%)
-
-
Sept 1995
-
-$8.40 M(+6.3%)
-$33.40 M(+4.4%)
June 1995
-
-$7.90 M(-11.2%)
-$32.00 M(+2.2%)
Mar 1995
-
-$8.90 M(+8.5%)
-$31.30 M(+1.6%)
Mar 1995
-$31.30 M(+21.8%)
-
-
Dec 1994
-
-$8.20 M(+17.1%)
-$30.80 M(+5.1%)
Sept 1994
-
-$7.00 M(-2.8%)
-$29.30 M(+4.3%)
June 1994
-
-$7.20 M(-14.3%)
-$28.10 M(+9.3%)
Mar 1994
-$25.70 M(+82.3%)
-$8.40 M(+25.4%)
-$25.70 M(+11.7%)
Dec 1993
-
-$6.70 M(+15.5%)
-$23.00 M(+13.9%)
Sept 1993
-
-$5.80 M(+20.8%)
-$20.20 M(+18.1%)
June 1993
-
-$4.80 M(-15.8%)
-$17.10 M(+21.3%)
Mar 1993
-$14.10 M(+213.3%)
-$5.70 M(+46.2%)
-$14.10 M(+45.4%)
Dec 1992
-
-$3.90 M(+44.4%)
-$9.70 M(+36.6%)
Sept 1992
-
-$2.70 M(+50.0%)
-$7.10 M(+34.0%)
June 1992
-
-$1.80 M(+38.5%)
-$5.30 M(+20.5%)
Mar 1992
-$4.50 M(+12.5%)
-$1.30 M(0.0%)
-$4.40 M(+7.3%)
Dec 1991
-
-$1.30 M(+44.4%)
-$4.10 M(+10.8%)
Sept 1991
-
-$900.00 K(0.0%)
-$3.70 M(-2.6%)
June 1991
-
-$900.00 K(-10.0%)
-$3.80 M(-2.6%)
Mar 1991
-$4.00 M
-$1.00 M(+11.1%)
-$3.90 M(+34.5%)
Dec 1990
-
-$900.00 K(-10.0%)
-$2.90 M(+45.0%)
Sept 1990
-
-$1.00 M(0.0%)
-$2.00 M(+100.0%)
June 1990
-
-$1.00 M
-$1.00 M

FAQ

  • What is Gilead Sciences annual net profit?
  • What is the all time high annual net income for Gilead Sciences?
  • What is Gilead Sciences annual net income year-on-year change?
  • What is Gilead Sciences quarterly net profit?
  • What is the all time high quarterly net income for Gilead Sciences?
  • What is Gilead Sciences quarterly net income year-on-year change?
  • What is Gilead Sciences TTM net profit?
  • What is the all time high TTM net income for Gilead Sciences?
  • What is Gilead Sciences TTM net income year-on-year change?

What is Gilead Sciences annual net profit?

The current annual net income of GILD is $5.67 B

What is the all time high annual net income for Gilead Sciences?

Gilead Sciences all-time high annual net profit is $18.11 B

What is Gilead Sciences annual net income year-on-year change?

Over the past year, GILD annual net profit has changed by +$1.07 B (+23.37%)

What is Gilead Sciences quarterly net profit?

The current quarterly net income of GILD is $1.25 B

What is the all time high quarterly net income for Gilead Sciences?

Gilead Sciences all-time high quarterly net profit is $4.68 B

What is Gilead Sciences quarterly net income year-on-year change?

Over the past year, GILD quarterly net profit has changed by -$927.00 M (-42.52%)

What is Gilead Sciences TTM net profit?

The current TTM net income of GILD is $126.00 M

What is the all time high TTM net income for Gilead Sciences?

Gilead Sciences all-time high TTM net profit is $18.11 B

What is Gilead Sciences TTM net income year-on-year change?

Over the past year, GILD TTM net profit has changed by -$5.75 B (-97.86%)